サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702372

静脈可視化装置の世界市場：2025年～2033年

Global Vein Illumination Devices Market - 2025-2033

出版日
ページ情報
英文 165 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
静脈可視化装置の世界市場：2025年～2033年
出版日: 2025年04月10日
発行: DataM Intelligence
ページ情報: 英文 165 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の静脈可視化装置の市場規模は、2024年に4億5,874万米ドルに達し、2033年には31億8,611万米ドルに達すると予測され、予測期間2025年のCAGRは21.3％になるとみられています。

静脈可視化装置は、近赤外光、透過照明、超音波などの技術を用いて静脈の可視性を向上させる先進医療ツールです。医療従事者が静脈の位置をより正確に特定し、静脈穿刺の失敗を減らし、静脈注射、採血、注入などの処置中の患者の快適性を向上させるのに役立ちます。特に、小児や高齢者、肥満や慢性疾患のある患者など、静脈へのアクセスが困難な患者に有用です。

世界の静脈可視化装置市場は、特に高齢者、小児、静脈の位置がわかりにくい患者に対する低侵襲医療処置への嗜好の高まりによって牽引されています。病院、献血センター、外来手術センターにおける高度な医療画像技術の需要も市場成長の原動力となっています。

近赤外線（NIR）や超音波ベースの静脈可視化のような技術の進歩は、静脈可視化装置の採用を増加させ、患者ケアや処置効率を向上させると予想されます。さらに、ロボット支援手術、インターベンショナルラジオロジー、外来診療の採用が増加していることは、手技の成功と患者の転帰の改善における静脈可視化装置の重要性をさらに強調しています。

世界の静脈可視化装置市場は、ヘルスケア専門家の限られた認識と適切なトレーニング不足による課題に直面しています。静脈穿刺の失敗を減らし、患者の快適性を向上させる効果があるにもかかわらず、多くの医療従事者は依然として伝統的な触診技術に頼っています。

また、近赤外線や超音波を利用した先進的なシステムの学習曲線も、普及に向けた課題となっています。開発途上地域では、体系的なトレーニングプログラムや実地経験が不足しているため、静脈可視化装置の日常的な医療処置への統合がさらに制限されています。

当レポートでは、世界の静脈可視化装置市場について調査し、市場の概要とともに、製品タイプ別、技術別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界見通し

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 製品タイプ別

  • テーブルトップデバイス
  • ハンドヘルドデバイス

第6章 技術別

  • 近赤外線（NIR）技術
  • 透過照明技術
  • 超音波技術

第7章 用途別

  • 静脈穿刺補助
  • IVアクセス
  • 採血
  • その他

第8章 エンドユーザー別

  • 病院と診療所
  • 献血センター
  • 外来手術センター
  • 学術研究機関

第9章 地域市場分析と成長機会

  • 北米
    • 地域特有の主要な動向
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 地域特有の主要な動向
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他
  • 南米
    • 地域特有の主要な動向
      • ブラジル
      • アルゼンチン
      • その他
  • アジア太平洋
    • 地域特有の主要な動向
      • 中国
      • インド
      • 日本
      • 韓国
      • その他
  • 中東・アフリカ
    • 地域特有の主要な動向

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • AccuVein Inc
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • Christie Medical Holdings, Inc
  • TransLite LLC
  • BLZ Technology Inc
  • VeinSight
  • Near Infrared Imaging, Inc.
  • Cambridge Medical（Venoscope）
  • VueTek Scientific LLC
  • NextVein LLC

第12章 仮定と調査手法

第13章 付録

目次
Product Code: MD9471

The global vein illumination devices market reached US$ 458.74 million in 2024 and is expected to reach US$ 3,186.11 million by 2033, growing at a CAGR of 21.3% during the forecast period 2025-2033.

Vein illumination devices are advanced medical tools that improve vein visibility using technologies like near-infrared light, transillumination, or ultrasound. They help healthcare professionals locate veins more accurately, reduce failed venipuncture attempts, and improve patient comfort during procedures like IV insertions, blood draws, and injections. They are particularly useful for patients with difficult venous access, such as children, the elderly, and those with obesity or chronic conditions.

Market Dynamics: Drivers & Restraints

Growing Demand for Minimally Invasive Procedures

The global vein illumination devices market is driven by the growing preference for minimally invasive medical procedures, particularly for elderly patients, pediatric populations, and those with difficult-to-locate veins. The demand for advanced medical imaging technologies in hospitals, blood donation centers, and ambulatory surgical centers is also driving market growth.

Technological advancements like near-infrared (NIR) and ultrasound-based vein visualization are expected to increase the adoption of vein illumination devices, improving patient care and procedural efficiency. Moreover, the increasing adoption of robotic-assisted surgeries, interventional radiology, and ambulatory care procedures further underscores the significance of vein illumination devices in ensuring procedural success and improving patient outcomes.

Limited Awareness and Training Among Healthcare Professionals

The global vein illumination devices market faces challenges due to limited awareness and lack of proper training among healthcare professionals. Despite their effectiveness in reducing failed venipuncture attempts and improving patient comfort, many medical practitioners still rely on traditional palpation techniques.

The learning curve associated with advanced near-infrared and ultrasound-based systems also poses a challenge for widespread adoption. In developing regions, there is a lack of structured training programs and hands-on experience, further limiting the integration of vein illumination devices into routine medical procedures.

Segment Analysis

The global vein illumination devices market is segmented based on product type, technology, application, end user and region.

Product Type:

The table-top devices from the product type segment are expected to dominate the vein illumination devices market with the highest market share

Table-top vein illumination devices are high-precision medical devices used in hospitals, clinics, and blood donation centers to enhance vein visibility using infrared or near-infrared technology. They assist healthcare professionals in locating veins, especially for patients with difficult venous access, such as the elderly, obese individuals, and pediatric patients. Their stable imaging quality, hands-free operation, and suitability for prolonged procedures improve venipuncture success rates and patient comfort.

The increasing adoption of table-top vein illumination devices is driven by the increasing prevalence of chronic diseases, the growing elderly and pediatric populations with hard-to-locate veins, and advancements in infrared imaging technology. The demand for minimally invasive procedures, patient comfort, and reduced procedural errors is also driving the adoption of these devices. The increasing number of blood donation drives and surgical procedures worldwide supports market expansion.

Geographical Analysis

North America is expected to hold a significant position in the vein illumination devices market with the highest market share

The North America vein illumination devices market is fueled by chronic diseases like diabetes, cardiovascular disorders, and obesity, which often cause difficult venous access. The growing demand for accurate venipuncture procedures in hospitals and clinics is driving market growth. Strong healthcare infrastructure and advanced medical technologies, along with the rising prevalence of chronic diseases in the U.S. and Canada, support the widespread integration of vein illumination devices.

For instance, according to the National Institute of Health, approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD), making it a leading cause of death for both men and women. Common types of cardiovascular disease include coronary heart disease (CHD), stroke, hypertension, and congestive heart failure. An estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent.

Competitive Landscape

The major global players in the vein illumination devices market include AccuVein Inc, Christie Medical Holdings, Inc, TransLite LLC, BLZ Technology Inc, VeinSight, Near Infrared Imaging, Inc, Cambridge Medical (Venoscope), VueTek Scientific LLC, and NextVein LLC, among others.

Key Developments

  • In December 2023, Polymatech Electronics introduced the vein detection light, a medical device that offers high-definition vein detection. The device provides real-time full HD visualisation of subdermal veins, ensuring clarity. The device weighs only five pounds and is designed for mobility, making it convenient for healthcare professionals to use in various medical settings. This technology is expected to revolutionize the healthcare industry.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global vein illumination devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Growing Demand for Minimally Invasive Procedures
      • 3.1.1.2. Surge in Demand for Point-of-Care and Home Healthcare Settings
    • 3.1.2. Restraints
      • 3.1.2.1. Limited Awareness and Training Among Healthcare Professionals
      • 3.1.2.2. High Cost of Advanced Vein Illumination Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of AI and Infrared Technology for Improved Accuracy
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Table-top Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Hand-held Devices

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Near-Infrared (NIR) Technology*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Transillumination Technology
  • 6.4. Ultrasound Technology

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Venipuncture Assistance*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. IV Access
  • 7.4. Blood Draw
  • 7.5. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Blood Donation Centers
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Academic & Research Institutions

9. Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. AccuVein Inc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Christie Medical Holdings, Inc
  • 11.3. TransLite LLC
  • 11.4. BLZ Technology Inc
  • 11.5. VeinSight
  • 11.6. Near Infrared Imaging, Inc.
  • 11.7. Cambridge Medical (Venoscope)
  • 11.8. VueTek Scientific LLC
  • 11.9. NextVein LLC

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us